| Metric | FY2025 | FY2024 | FY2023 | FY2023 | FY2023 | FY2023 | FY2022 | FY2022 | FY2022 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Premiums | $49.78B+10.8% | $44.95B+1.5% | $44.28B-8.7% | $48.51B+17.9% | $41.15B | — | $48.51B | — | — | — |
| Universal life and investment-type product policy fees | $5.00B+0.6% | $4.97B-3.5% | $5.15B-1.4% | $5.22B-0.4% | $5.24B | — | $5.22B | — | — | — |
| Net investment income | $22.56B+6.0% | $21.27B+6.9% | $19.91B+25.1% | $15.92B-25.6% | $21.39B | — | $15.92B | — | — | — |
| Other revenues | $2.83B+8.7% | $2.60B+3.0% | $2.53B-4.0% | $2.63B+0.4% | $2.62B | — | $2.63B | — | — | — |
| Net investment gains (losses) | -$1.15B+3.3% | -$1.18B+58.1% | -$2.82B-124.1% | -$1.26B-181.7% | $1.54B | — | -$1.26B | — | — | — |
| Net derivative gains (losses) | -$1.94B-19.5% | -$1.62B+24.2% | -$2.14B+4.9% | -$2.25B+30.9% | -$3.26B | — | -$2.25B | — | — | — |
| Total revenues | $77.08B+8.6% | $70.99B+6.1% | $66.91B+321.7% | $15.87B-4.6% | $16.62B+8.0% | $15.39B-77.6% | $68.77B+208.6% | $22.28B+44.0% | $15.47B+0.4% | $15.40B |
| Policyholder benefits and claims | $49.72B+11.2% | $44.73B+0.3% | $44.59B-9.9% | $49.51B+14.8% | $43.12B | — | $49.51B | — | — | — |
| Policyholder liability remeasurement (gains) losses | -$150.0M+27.2% | -$206.0M-357.8% | -$45.0M-139.5% | $114.0M+166.3% | -$172.0M | — | $114.0M | — | — | — |
| Market risk benefit remeasurement (gains) losses | -$508.0M+54.2% | -$1.11B-11.6% | -$994.0M+72.9% | -$3.67B-197.0% | -$1.24B | — | -$3.67B | — | — | — |
| Interest credited to policyholder account balances | $8.95B+7.3% | $8.34B+6.1% | $7.86B+101.8% | $3.89B-30.1% | $5.57B | — | $3.89B | — | — | — |
| Policyholder dividends | $553.0M-7.1% | $595.0M-4.3% | $622.0M-11.9% | $706.0M-19.8% | $880.0M | — | $706.0M | — | — | — |
| Other expenses | $13.86B+6.5% | $13.02B+2.4% | $12.71B+7.2% | $11.86B-1.3% | $12.02B | — | $11.86B | — | — | — |
| Total expenses | $72.42B+10.8% | $65.36B+1.0% | $64.74B+322.3% | $15.33B-5.3% | $16.19B+7.0% | $15.13B-75.8% | $62.41B+199.1% | $20.87B+44.1% | $14.49B+7.5% | $13.47B |
| Income (loss) before provision for income tax | $4.66B-17.1% | $5.62B+160.0% | $2.16B-66.0% | $6.36B-25.3% | $8.52B | — | $6.36B | — | — | — |
| Provision for income tax expense (benefit) | $1.26B+6.8% | $1.18B+110.4% | $560.0M-47.3% | $1.06B-35.3% | $1.64B | — | $1.06B | — | — | — |
| Net income (loss) | $3.40B-23.4% | $4.44B+177.4% | $1.60B+223.6% | $495.0M+21.3% | $408.0M+380.0% | $85.0M-98.4% | $5.30B+354.3% | $1.17B+27.5% | $915.0M-44.2% | $1.64B |
| Less: Net income (loss) attributable to noncontrolling interests | $24.0M+33.3% | $18.0M-25.0% | $24.0M+300.0% | $6.0M+0.0% | $6.0M+20.0% | $5.0M-72.2% | $18.0M+260.0% | $5.0M+0.0% | $5.0M+0.0% | $5.0M |
| Net income (loss) attributable to MetLife, Inc. | $3.38B-23.7% | $4.43B+180.5% | $1.58B+222.7% | $489.0M+21.6% | $402.0M+402.5% | $80.0M-98.5% | $5.28B+354.7% | $1.16B+27.7% | $910.0M-44.3% | $1.63B |
| Less: Preferred stock dividends | $194.0M-3.0% | $200.0M+1.0% | $198.0M+195.5% | $67.0M+109.4% | $32.0M-51.5% | $66.0M-64.3% | $185.0M+189.1% | $64.0M+120.7% | $29.0M-54.0% | $63.0M |
| Preferred Stock Redemption Premium | $12.0M | $0 | $0 | $0-100.0% | $6.0M | — | — | — | — | — |
| Net income (loss) available to MetLife, Inc.’s common shareholders | $3.17B-24.9% | $4.23B+206.2% | $1.38B+227.0% | $422.0M+14.1% | $370.0M+2542.9% | $14.0M-99.7% | $5.10B+364.4% | $1.10B+24.6% | $881.0M-43.9% | $1.57B |
| Basic | $4.7M-20.7% | $6.0M+228.6% | $1.8M+225.0% | $560K+16.7% | $480K+2300.0% | $20K-99.7% | $6.3M+360.1% | $1.4M+26.6% | $1.1M-42.9% | $1.9M |
| Diluted | $4.7M-20.7% | $5.9M+228.2% | $1.8M+223.2% | $560K+16.7% | $480K+2300.0% | $20K-99.0% | $2.0M+43.1% | $1.4M+26.9% | $1.1M-42.9% | $1.9M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.